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Abstract
In vitro suicide by tritiated thymidine (3H-TdR), hydroxyurea 
(HU), or cytosine arabinoside (Ara-C) is assumed to reflect the 
proportion of colony-forming cells in S-phase at the time of 
exposure. However, these techniques are not always accurate. 
Nonradioactive iododeoxyuridine (IdUrd) is incorporated 
into DNA during S-phase and can be detected by monoclonal 
antibodies. In the present study, a new IdUrd application was 
developed to investigate the kinetics of hematopoietic pro­
genitor cells. After incubation with IdUrd, colony-forming 
cells were cultured in semisolid assay. An immunoperoxidase 
staining protocol was developed to detect IdUrd in ceils of 
colonies in agar. Colony-forming cells in S-phase during the 
IdUrd exposure were postulated to give rise to IdUrd+ 
colonies, whereas non-S-phase cells would generate IdUrd” 
colonies. Toxicity, sensitivity, and IdUrd inactivation studies 
indicated that progenitor cells could safely be pulse-labeled 
for 2 hours with 40 pM IdUrd, whereas prolonged labeling 
with 1 jiM IdUrd was at least feasible for 5 days.
Molt-4 cells and normal bone marrow cells were used to 
compare IdUrd pulse-labeling with 3H-TdR suicide. Part of 
the Molt-4 cells were enriched for Gt- and S-phase cells by 
counterflow centrifugation. The bone marrow cells were 
either unstimulated or stimulated with growth factors. As a 
result, the accuracy of both techniques could be tested in 
populations with different quantities of S-phase cells. Wide 
confidence intervals of the suicide technique contrasted with 
the small confidence intervals obtained with IdUrd pulse- 
labeling. For instance, the fraction of Molt-4 cells with 27.8% 
S-phase cells contained 17.7% (confidence interval -8.2 to 
43.6%) clonogentc cells in S-phase when determined with 
3H-TdR suicide. Of this fraction, the percentage of clonogenic 
cells in S-phase was 30.6% with a confidence interval of 25,5 
to 36.2% when determined with IdUrd pulse-labeling. In our 
hands, the IdUrd pulse-]abeling was more accurate than the 
3H-TdR suicide technique,
Thus far, kinetic studies of progenitors have been limited 
to the determination of the fraction of S-phase cells by sui­
cide techniques. By prolonged IdUrd labeling, it is now possi­
ble to determine the proliferating fraction of progenitor cells.
Key words: Iododeoxyuridine—Colony-forming cells
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Introduction
Normal and leukemic progenitor cells can be cultured in 
vitro by semisolid assay [1], This enables kinetic studies of
these cells. Insight into the proliferative behavior of pro­
genitors will help to understand the biology of the hemato­
poietic system under physiologic and pathological condi­
tions. Furthermore, therapeutic interventions, such as 
exposure to cytostatic drugs or growth factors, can be evalu­
ated. The proliferative status of progenitors can be studied in 
vitro by suicide techniques [2,3]. After short-term exposure to 
3H-TdR, HU, or Ara-C, the loss of progenitor cells is deter­
mined by colony-forming assay. The fractional reduction in 
cloning efficiency is considered to reflect the proportion of 
colony-forming cells in S-phase at the time of exposure. The 
estimation of progenitors in S-phase by suicide techniques 
may not always be accurate [2,4,5]. It has been reported that 
non-S-phase cells, probably late cells, can take up 3H-TdR 
and eventually will be killed [4,5], Nevertheless, the com­
monly applied 3H-TdR suicide seems to be the most reliable 
of the available techniques [4].
Previously, IdUrd has become available for kinetic studies. 
This nonradioactive thymidine analog is incorporated into 
DNA during S-phase and can be detected by anti-IdUrd anti­
bodies [6,7]. Using flow cytometry (FCM) or immunocyto- 
chemistry, S-phase fractions of both normal and malignant 
cells have been determined [8-12],
To our knowledge, proliferation of hematopoietic pro­
genitors has not been studied with IdUrd. The present study 
was designed to develop a new IdUrd technique to investi­
gate the kinetic behavior of colony-forming cells. During 
IdUrd exposure, only progenitor cells in S-phase will incorpo­
rate IdUrd into their DNA. Subsequently, when a colony- 
forming assay is performed, a single progenitor cell will form 
one colony. Cell division is expected to result in the distribu­
tion of parental DNA over the daughter cells. Therefore, 
detection of incorporated IdUrd in the cells of a particular 
colony will indicate that it originated from a colony-forming 
cell that has been in S-phase during the labeling period. 
Colony-forming cells not in S-phase during exposure will 
give rise to IdUrd” colonies. The fraction of progenitor cells in 
S-phase can be determined by pulse-labeling. The total pro­
portion of cycling progenitors can be assessed after a pro­
longed labeling period.
Labeling of cells with 10 pM IdUrd for 30 minutes proved 
to be optimal for kinetic analysis by FCM [8,9,13]. With 
FCM, cells are analyzed immediately after labeling. As a 
result, dilution of the IdUrd signal due to cell division occurs 
infrequently. In contrast, IdUrd* colonies derive from labeled 
clonogenic cells that have divided several times to form a 
colony. To prevent that, the IdUrd signal will become unde-
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tectable, the concentration used to pulse-labei progenitors 
should be sufficiently high, and the labeling period should be 
as long as theoretically justified.
A 52% reduction in myeloid colonies was observed in a 
study in which normal bone marrow was incubated with 
5 pM IdUrd for 24 hours [14]. IdUrd can be catabolized to 
5-iodouracil (IUra) and further degradated [14]. Therefore/ 
toxicity and IdUrd inactivation were considered to be major 
limitations for prolonged labeling.
In the present study, sensitivity, toxicity, and IdUrd inac­
tivation were evaluated to determine the optimal concentra­
tion for pulse and prolonged labeling. A previously published 
protocol developed for immunologic detection of IdUrd by 
F CM was improved and adjusted for application on agar cul­
tures [13]. Comparative studies with 3H-TdR suicide were per­
formed to establish the accuracy of IdUrd pulse-labeling.
It appeared that the fraction of colony-forming cells in S- 
phase can be determined more accurately with IdUrd pulse- 
labeling than with 3H-TdR suicide. Moreover, prolonged 
IdUrd labeling may create the ability to assess the fraction of 
proliferating progenitors.
Materials and methods
Bone marrow collection, cryopreservationf and thawing
Normal bone marrow cells were obtained from healthy bone 
marrow donors. Informed consent was given in all cases. The 
cells were collected in sterile buffered acid-citrate dextrose (pH 
7.0) and enriched for clonogenic cells by flotation centrifuga­
tion [15]. In short, cells were mixed with Percoll (Pharmacia, 
Uppsala, Sweden) to obtain a density of 1.085 g/mL. From 
this suspension, 15 mL was layered tinder 30 mL of a 1.067 
g/mL Percoll solution with 5 mL Hanks' balanced salt solution 
(HBSS) (Flow Laboratories, Irvine, Scotland) on top of it. After 
centrifugation, the cells with a density of <1.067 g/mL were 
collected and frozen in liquid nitrogen using a temperature- 
controlled freezer (Kryo 10; Planer Biomed, Sunbury, Middle­
sex, UK). Each vial contained 5xl06 cells in Iscove's modified 
Dulbecco's medium (IMDM) (Flow Laboratories), supplement­
ed with 10% heat-inactivated fetal calf serum (FCS) (HyClone, 
Logan, UT), 50 IU/mL penicillin, 50 pg/mL streptomycin 
(both Flow Laboratories), and 10% DMSO. Just prior to the 
experiments, cells were thawed in a 37°C waterbath, resulting 
in a recovery of >90%, Freezing and thawing procedures have 
been described in detail elsewhere [16].
Recombinant human growth factors
Recombinant human interleu kin-3 (rhIL-3) and granulocyte- 
macrophage colony-stimulating factor (GM-CSF) were a kind 
gift of Sandoz BV (Uden, The Netherlands). rhG-CSF was 
kindly donated by Boehring (Marburg; Germany). Final con­
centrations of 40 ng/mL, 20 ng/mL, and 5 ng/mL of each, 
respectively, were used and resulted in plateau stimulation.
Pulse and prolonged IdUrd labeling
Normal bone marrow cells (104 cells/mL) were suspended in 
IMDM supplemented with 20% FCS, 50 IU/mL penicillin, 
and 50 pg/mL streptomycin. The cultures were either unstim­
ulated or stimulated with the combination of IL-3, GM-CSF, 
and G-CSF. IdUrd (Sigma, St. Louis, MO) dilutions were pre­
pared from freshly thawed stock solution. Based on the expe­
rience with FCM, pulse-labeling was performed for 2 hours at 
final concentrations of 5, 10, 20, 40, 60, and 80 pM IdUrd. In 
prolonged labeling, IdUrd at final concentrations of 0.5, 1, 2,
3, 4, 5, and 10 pM was added to the suspensions. Cells were 
labeled for a period of 1, 2, 2, 4, and 5 days. Labeling was per­
formed at 37°C in a fully humidified atmosphere containing
5% CO2 in air. Subsequently, cells were washed three times 
with glucose-phosphate-buffered saline (G-PBS). The cell pel­
let was resuspended in FCS and used for clonogenic assay and 
cytocentrifugation. In each experiment, one sample not 
labeled with IdUrd was identically processed and served as 
negative control. The supernatants of the cell suspensions, 
incubated for 1 to 5 days with 1 pM IdUrd, were collected 
before washing and preserved at -20°C to determine the 
remaining IdUrd content by bioassay.
Clonogenic assay (CFU-GM)
Cells were cultured in IMDM supplemented with 20% FCS, 
50 IU/mL penicillin, 50 pg/mL streptomycin, and 0.3% 
(wt/vol) bacto-agar (Difco, Detroit, MI). Cells were stimulated 
with the combination of IL-3, GM-CSF, and G-CSF, Dupli­
cates were cultured in 35xl0-m m  culture dishes (Costar, 
Cambridge, MA) at 37°C in a fully humidified atmosphere 
containing 5% COz in air. To obtain 200 to 400 aggregates 
per dish, 2 to 4X104 cells in a total volume of 0.85 mL were 
plated. The cultures ended after 5 to 7 days when aggregates 
consisted of 20 to 60 cells. After counting the clusters (5 to 40 
cells) and colonies (>40 cells), the agar cultures were dried by 
cytocentrifugation and used for immunoperoxidase staining,
Cytocentrifugation of cells
Cells in suspension were sedimented onto a microscope slide 
by cytocentrifugation (Shandon, Pittsburgh, PA). Filter cards 
were moistened with 100 pL 5% human serum albumin 
(HSA) in PBS. Next, 50 pL of a cell suspension with a concen­
tration of 5x l0s/mL was added in the sample chamber. The 
samples were centrifuged at 500 rpm during 10 minutes. The 
sedimented cells were assessed for IdUrd incorporation by 
immunoperoxidase staining.
Cytocentrifugation of agar cultures
The method used for cytocentrifugation of agar cultures is a 
modification of the method described by Baines [17], Cul­
tures were cut into halves and shaken into G-PBS. Each half 
was lifted onto a 76x26-mm alcohol-cleaned glass slide and 
covered with a cellulose acetate strip (Sepraphore; Gelman 
Sciences, Ann Arbor, MI). Next, a piece of filter paper (Schle­
icher & Schuell, Dassel, Germany) was put on top, followed 
by a filter card. The cultures were partially dried during 30 to 
60 minutes at room temperature. Subsequently, the slides 
were put into cytoclips together with the plastic sample 
chambers. They were centrifuged in a cytospin centrifuge at 
1500 rpm for 10 minutes. After removal of the filters, a thin 
agar layer, in which the cells were embedded, remained on 
the glass slide.
Detection of incorporated IdUrd by indirect immunoperoxidase staining
The method used to detect incorporated IdUrd was based on 
a previously published protocol developed for flow cytometry 
[13]. A line was drawn around the sedimented cells or dried 
agar cultures with a Dako Pen (Dakopatts, Glostrup, Den­
mark) to keep the solutions on the slides. After an initial 
wash step in PBS, a 1 mg/mL pepsine (Serva, Heidelberg, Ger­
many) 2M HC1 solution was applied to make the DNA acces­
sible for the antibodies and to neutralize endogenous peroxi­
dase activity in the cytoplasm. After 30 minutes, 0.1M 
Na2B40 7 was added for neutralization. Next, pooled human 
serum (PITS) (20% in PBS) was applied to block aspecific bind' 
ing sites. Subsequently, a specific monoclonal anti-IdUrd 
antibody produced in our institute (HN-IU; dilution 1:10) 
was added [12], Binding of the anti-IdUrd antibody was visu­
alized by adding the following antibodies; peroxidase-conju­
gated rabbit antimouse immunoglobulins (dilution 1:100,
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Dakopatts), peroxidase-conjugated goat antirabbit immuno­
globulins (dilution 1:250; ICN Biomedicals, Costa Mesa, CA), 
and peroxidase-conjugated rabbit antigoat immunoglobulins 
(dilution 1:250; ICN Biomedicals). Slides were washed in PBS 
in between each step. The incorporated, labeled IdUrd was 
visualized with 0.5 mg/mL 3,3-diaminobenzidin tetrahydro- 
chloride (DAB) (Sigma) and 0,015% H20 2 at pH 7.8 in PBS. 
After 10 to 12 minutes incubation at 37°C, the slides were 
washed by running them under tap water for 10 minutes, 
counterstained with hematoxylin solution (Merck, Darm­
stadt, Germany), and fixated with alcohol (70, 80, 90, 96, 
100, 100, and 100%) and xylene substitute (Shandon). The 
slides were covered with Malinol (Schmid, Kongen, Ger­
many) and a 24x50-mm glass slide for microscopic examina­
tion. In each experiment, a sample not labeled with IdUrd 
was identically treated and served as negative control.
Scoring
A cell was considered IdUrd4* when its nucleus contained one 
or more brown-black spots or when the nucleus was colored 
totally brown-black. Aggregates were considered positive 
when >50% of the cells in the aggregate were positive for 
IdUrd. Per experiment, 100 to 200 aggregates were analyzed. 
The percentage of positive aggregates was calculated as: 
[number of IdUrd+ aggregates/(number of IdUrd* aggregates + 
number of IdUrd” aggregates)]xl00. All experiments were 
analyzed by one individual.
Thymidine suicide
A modification of the method of Becker et al. [3] was used for 
thymidine suicide. Cells (104/mL) were suspended in IMDM 
supplemented with 20% FCS, 50 IU/mL penicillin, and 50 
jig/mL streptomycin, and half of the specimen was exposed 
for 30 minutes to 3H-TdR (25 Ci/mM and 1 mCi/mL) at 37°C. 
The final concentration was 100 pCi/mL. Subsequently, cells 
were washed three times with cold G-PBS containing 100 pg 
cold thymidine per mL. The remaining cell pellet was resus­
pended in FCS and used for clonogenic assay. The other half 
of the cells was not exposed to 3H-TdR; the cells were incu­
bated, washed, and plated in agar identically to the suicided 
specimen and served as controls. The percentage of pro­
genitor cells in S-phase was calculated as: [(number of control 
aggregates -  number of aggregates after 3H-TdR exposure)/ 
number of control aggregates] X100.
AIo/t-4
The human (mycoplasma-free) leukemic cell line Molt-4 was 
cultured in RPMI 1640 (Flow Laboratories) and supplemented 
with 10% FCS, 50 IU/mL penicillin, 50 pg/mL streptomycin, 
and 2 mM L-glutamin (Flow Laboratories) in a 5% C02 humi­
dified atmosphere at 37°C. The cell density was 0.25 to
1.0X106 cells/mL. Exponentially growing cells were exposed 
to IdUrd (40 pM), 3H-TdR (100 pCi/mL), or medium (control) 
for 30 minutes at 37°C, After subsequent washing with cold 
G-PBS (containing 100 pg cold thymidine per mL), part of 
the cells were used for counterflow centrifugation. Of the 
remaining noncentrifuged cells, one fraction was used for 
clonogenic assay and another was fixed in cold 75% ethanol 
[13] for DNA analysis.
Mo it-4 clonogenic assay
Cells were cultured in RPMI 1640 supplemented with 10% 
FCS, 50 IU/mL penicillin, 50 pg/mL streptomycin, 2 mM 
L-glutamin, and 0.3% (wt/vol) bacto-agar. Per experiment, 
eight 35xl0-mm dishes containing 500 cells in 0.85 mL 
medium were cultured at 37°C in a fully humidified atmos­
phere containing 5% C02. After 4 days, the aggregates (eight 
to 32 cells) were counted. Agar cultures of IdUrd-labeled cells 
were dried by cytocentrifugation and used for immunoperox- 
idase staining.
Counterflow centrifugation of Molt-4 ceils
Counterflow centrifugation (CC) was performed with a mul­
tichamber rotor (Curame 3000; Dijkstra Vereenigde, Amster­
dam, The Netherlands) to enrich Molt-4 cells in Gt and 
S-phase [18], The elutriation profiles proved to be identical 
for the different chambers [18]. One chamber contained con­
trol cells, a second chamber thymidine-labeled cells, and a 
third IdUrd-labeled cells. Cells collected at a decreasing rotor 
speed showed a progressively larger cell volume and repre­
sented distinct populations of cells in transition from Gl 
phase, through S-phase to G2M phase. On the basis of DNA 
histograms, collected fractions were combined to obtain four 
different fractions representing an "early" and "late" Gt frac­
tion and an "early" and "mid" S-phase fraction. Of each frac­
tion, cells were used for DNA analysis and clonogenic assay.
Bivariate flow-cytometnc IdUrd/DNA analysis in suspension
Bivariate staining for IdUrd incorporation and DNA content 
was performed using the simultaneous proteolytic enzyme 
digestion and acid denaturation technique [13,19]. The anti- 
IdUrd HN-IU MoAb and a fluorescein isothiocyanate (FITC)- 
conjugated IgG goat antimouse second-step antibody (GAM- 
FITC) (American Qualex International, La Mirada, CA) were 
used for detection of IdUrd. Propidium iodide (PI) was used 
for DNA staining, IdUrd staining of the cell suspensions was 
always performed in duplicate, and all incubation steps were 
executed in the dark. Non-IdUrd-labeled low-density blood 
cells served as negative controls. Samples were analyzed on a 
Coulter Epics Elite (Coulter, Hialeah, FL) flow cytometer 
equipped with a 40 mW Argon ion laser running at 15 mW. 
A high-pass filter of 610 nm for red fluorescence (PI), a band­
pass filter 525/30 for green fluorescence (FITC), and a 
dichroic mirror of 550 nm were used. A minimum of 20,000 
cells was analyzed in duplicate. The fluorescence signals were 
recorded on a linear scale in list mode. The labeling index 
was defined as the percentage of IdUrd-labeled cells.
Bioassay for the detection of residuai IdUrd after prolonged labeling
Normal bone marrow cells were suspended in IMDM con­
taining 20% FCS and the combination of IL-3, GM-CSF, and 
G-CSF. The cells were cultured in an incubator for 3 days to 
attain a high proportion of proliferating cells. After washing 
with G-PBS, the pelleted stimulated cells were suspended in 
thawed supernatants and cultured in an incubator for anoth­
er 24 hours. The used supernatants were collected from cell 
suspensions and incubated with 1 pM IdUrd for a period of 
1 to 5 days. As control, cells were also exposed to freshly pre­
pared 1 pM IdUrd. After incubation, the cells were washed 
with G-PBS. The cell pellet was resuspended in FCS and used 
for cyto centrifugation and clonogenic assay. Subsequently, 
immunoperoxidase staining was performed to determine 
whether the supernatants contained sufficient IdUrd to label 
cells in S-phase.
Statistics
Values were expressed as mean ± 95% confidence interval 
(Cl) of the mean. After IdUrd labeling, the binomial distribu­
tion was applied to calculate the 95% Cl of the mean per­
centage of progenitors in S-phase. Significance of IdUrd con­
centration level was tested with variance analysis (ANOVA 
with Duncan-Waller test) [20],
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Fig. 1. Examples of IdUrd* aggregates. A. Normal CFU-GM cultured after 24-hour labeling with 1 pM IdUrd. B. Molt-4 aggre­
gate cultured after pulse-labeling with 40 pM IdUrd.
Results
Development of the detection of incorporated idUrd
Immunoperoxidcise staining. The first step was the adaptation 
of the protocol for IdUrd detection by immunofluorescence 
developed for FCM [13]. In our hands, it was difficult and 
time-consuming to identify aggregates in agar cultures when 
fluorescence was used; we preferred an immunoperoxidase 
staining technique* This allowed evaluation by light 
microscopy. All aggregates, whether positive for IdUrd or not, 
could easily be visualized after counterstaining. A sandwich 
method of three subsequent additions of peroxidase-conju- 
gated immunoglobulins was chosen. Intensification of the 
signal with these three peroxidase-conjugated immunoglobu­
lins proved to be superior to the signal obtained with only 
one or two peroxidase-conjugated immunoglobulins (data 
not shown).
Adaptation of the semisolid (agar) culture and culture time, 
Instead of the usual 2.0 mL, a reduced volume of 0.85 mL 
agar per dish was plated. Incorporated IdUrd was more easily 
accessible for antibodies when the thickness of the agar cul­
ture was reduced. Subsequent mitoses of the clonogenic cell 
are expected to dilute the IdUrd signal, which may result in 
false-negative colonies. The percentage of IdUrd* bone mar­
row colonies after 7 culture days (average colony size=64 
cells) was the same as determined after 3 days (average cluster 
size=16 cells; data not shown). This indicated that the 
immunoperoxidase staining was at least sensitive enough to 
detect IdUrd in colonies consisting of maximally 64 cells. All 
cells present in smaller clusters contained at least three spots, 
whereas most, but not always all, cells of the larger colonies 
contained one or a few spots (Fig. 1).
Pulse-labeling
Toxicity. The IdUrd toxicity was tested on three different nor­
mal bone marrows. The cells were cultured for 4 days in the 
presence of the combination of IL-3, GM-CSF, and G-CSF to
obtain a high proportion of cycling progenitors. IdUrd was 
added during the last 2 hours of incubation. The number of 
CFU-GM was not significantly reduced, even after incubation 
with 80 pM IdUrd (Fig. 2). However, the size of the aggre­
gates cultured after incubation with 80 ]iM IdUrd was small­
er compared to control cultures. Therefore, 80 \iM was con-
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Fig. 2. Toxicity of IdUrd pulse-labeling with IL-3-, 
GM-C5F-, and G-CSF-stimulated CFU-GM. Normal bone 
marrow cells were labeled with various concentrations of 
IdUrd for 2 hours. Subsequently, the number of CFU-GM 
was determined and expressed as a percentage of the 
control cultures (incubated without IdUrd). The graphic 
represents the mean percentage (±95% Cl) of three nor­
mal bone marrows.
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Fig. 3. Signal intensity after IdUrd pulse-labeling. Normal 
bone marrow cells from three donors were labeled with 
various concentrations of IdUrd for 2 hours. Subsequently, 
clonogenic assays were performed. Cultures were ended 
after 6 days and the incorporated IdUrd was detected by 
¡mmunoperoxidase staining. The diagram shows the mean 
(±95% Cl) percentage of positive (□ ) and negative (■ ) 
colonies for each IdUrd concentration. Colonies in which 
the brown staining was too vague to determine whether 
they were positive or negative are represented as undeter­
mined (IS).
side red to be toxic. In addition, peroxidase staining was per­
formed on sedimented cells of the suspensions after labeling 
with the different IdUrd concentrations. All samples con­
tained IdUrd* cells. Part of the cells labeled with 80 pM were 
covered with a brown smear. It appeared as if their nuclei 
were no longer intact. This, again, suggested toxicity.
Signal intensity. Cells were pulse-labeled for a period of 2 hours. 
Because of an insufficient amount of incorporated IdUrd, a 
shorter period may underestimate the number of clonogenic 
cells in 5-phase, whereas a longer period may result in overesti­
mation. Pulse-labeling with 5 pM IdUrd resulted in a 
significantly lower percentage of positive aggregates when
compared to the other tested IdUrd concentrations. The mean 
(±95% Cl) positive percentage was 22±20 after pulse-labeling 
with 5 pM vs. 42±8, 37 ±12, and 45±12 after labeling with 10,
20, and 40 pM, respectively (Duncan-Waller; n=3; p<0.05) 
(Fig. 3). The percentages of positive aggregates after labeling 
with 10, 20, and 40 pM IdUrd were not significantly different. 
The lower percentage of positive aggregates found after 80 pM 
labeling suggested toxicity toward colony-forming cells that 
incorporated IdUrd. After labeling with 5, 10; and 20 pM 
IdUrd, the brown staining in a small percentage (<10%) of the 
aggregates was too vague to determine whether they were pos­
itive or negative. Taking both toxicity and signal intensity into 
account, 40 pM was considered to be the optimal IdUrd con­
centration for pulse-labeling.
Sensitivity. Molt-4 cells were used to check whether all clono- 
genic cells in S-phase were sufficiently pulse-labeled with 
IdUrd to be detected by immunoperoxidase staining. If not, 
an underestimation of the percentage of colony-forming cells 
in S-phase may occur. In contrast to normal bone marrow 
cells, Molt-4 cells have a high plating efficiency (20 to 50%). 
Therefore, cell cycle analysis of the total cell population can 
be considered to approximate the cycling status of the 
colony-forming cells. The percentage Molt-4 cells in S-phase 
was determined by FCM using IdUrd incorporation. After 
pulse-labeling, 40.9% of the overall Molt-4 cell population 
was in S-phase, whereas 45,6% (41.1 to 50.3; mean ± 95% Cl) 
of the colonies were IdUrd* (Table 1).
In addition, Molt-4 cells were elutriated to create cell pop­
ulations with an increasing number of S-phase cells. This 
allowed evaluation of the accuracy of IdUrd pulse-labeling 
under different conditions. The percentage of S-phase cells 
increased from 13.2% in fraction 1 to 69.9% in fraction 4 
(Table 1). The percentage of IdUrd* CFU-Molt-4 increased 
from 14.8% (11.4 to 29.0) in fraction 1 to 70.1% (64.9 to 
74.8) in fraction 4. The percentage of IdUrd* colonies corre­
sponded strongly with the percentage of S-phase cells.
Comparison of 3H-TdR suicide and IdUrd pulse-labeling. IdUrd 
pulse-labeling was compared with 3H-TdR suicide, which is 
considered to be the most reliable suicide technique [4]. 
Unfractionated Molt-4 cells and Molt-4 cell fractions contain­
ing different quantities of S-phase cells were tested. The frac­
tions were obtained by counterflow centrifugation. Compari­
son between the suicide index and the percentage of IdUrd*
Table 1. Comparison of the percentage of clonogenic Molt-4 cells in S-phase determined by 3H-TdR suicide and IdUrd pulse-labeling in 
CC fractions containing different percentages of S-phase cells
CC
fraction3
Percent 
S-phase cellsb
CFU-Moltc 
Control 3H-TdR
Suicide 
index (%)d
ldUrd+
CFU-Molte
Total 40.9 106.6±7.6 59.8±9.0 43.9 45.6
283-59.5 41.1-50.3
1 13.2 14.6±2.0 15,3±3.2 —4.8 14.8
-40.4-30.8 11.4-19.0
2 27.8 31.6±5.6 26.0±2.6 17.7 30.6
♦ -8.2-43.6 25.5-36.2
3 45.8 65.9±4.2 26,0±3.4 60.5 52.2
49.0-72.0 46.0-58.4
4 69.9 92.5±8.0 11.1±3.2 88.0 70.1
75.9-100.1 64.9-74.8
fractions (1 to 4) obtained with CC at decreasing rotor speed. The total fraction represents Molt-4 cells that were not elutriated. 
Percentage of Molt-4 cells in S-phase determined by IdUrd incorporation. 
cMean number (±95% Cl; n=8 cultures) of Molt-4 colonies/500 cells.
dMean percentage (±95% Cl; n=8 cultures) of CFU-Molt-4 in 5-phase determined by 3H-TdR suicide. 
eMean percentage (±95% Cl; n-8 cultures) of CFU-Molt-4 in S-phase determined by IdUrd pulse-labeling.
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Table 2. Comparison of the percentage of CFU-GM in S-phase determined by 3H-TdR suicide and IdUrd pulse-labeling in four normal 
bone marrows
Case no. Culture condition1 Control
CFU-GM3
3H-TdR Suicide index (%)c ldUrd+ CFU-GM (%)d
1 Unstimulated 154.3±20.9 189.5±19.4 -22.8 4.2
-48.8-3.2 1.8-9.5
Stimulated 409.0±34.3 343.7±63.7 16.0 33.3
-7.9-39.9 27.5-39.8
2 Unstimulated 108.7±18.3 107.3±5.2 1.3 8.3
-20.3-22.9 4,4-15.0
Stimulated 328,7±12.7 163.3±19.2 50.3 56.5
n 40.7-59.6 49.3-63.4
3 Unstimulated 98,5±20.0 96.0±2.8 2.5 10.4
-20.6-25.6 6.6-16.0
Stimulated 214.0±71.2 64.7±15.0 69.8 48.2
29.6-110.0 42.1-54.4
4 Fresh 446.5±84,9 293.5±31.0 34.2 20.3
8.2-60,2 14.2-28.3
Unstimuiated 176.0±15.1 164.0±36.7 6.8 9.3
-22.6-36.2 5.6-15.1
Stimulated 140.7±7,4 63.0±11.0 55.2 36.4
34.4-76,0 30.4-42.9
aMean number of CFU-GM/0.3X105 nucleated cells (±95% Cl, n=6).
bThawed normal bone marrow cells were tested 4 days after liquid culture in the absence (unstimulated) or presence (stimu­
lated) of the combination of IL-3, GM-CSF, and G-CSF. tn case 4, freshly obtained bone marrow cells were also tested. 
Percentage (±95% Cl, n=6 cultures) of CFU-GM in S-phase determined by 3H-TdR suicide.
Percentage (±95% Cl, n=200 aggregates) of CFU-GM in S-phase determined by IdUrd pulse-labeling.
combination of IL-3, GM-CSF, and G-CSF to generate colony- 
forming cells with a low and high proliferative activity, 
respectively. In unstimulated thawed bone marrow, the per­
centage of CFU-GM in S-phase varied from -23 to 7% when 
determined with thymidine suicide and from 4 to 10% when 
assessed with IdUrd pulse-labeling (Table 2). After stimula­
tion with the combination of growth factors, the percentage 
of CFU-GM in S-phase ranged from 16 to 70% (3H-TdR sui­
cide) and 33 to 56% (IdUrd pulse-labeling). No significant 
differences were observed between the percentages obtained 
with 3H-TdR suicide and IdUrd labeling. The confidence 
intervals of the suicide index were again much wider than 
those of the IdUrd pulse-labeling. The fresh bone marrow 
sample showed a higher percentage of clonogenic cells in S- 
phase with both methods, probably owing to the presence of 
viable CSF-producing monocytes in this sample (Table 2, 
sample 4).
Prolonged labeling
Toxicity of various concentrations of IdUrd during 5~day incuba­
tion. The toxicity was tested on three normal bone marrows. 
Cells were stimulated with the combination of IL-3, GM-CSF, 
and G-CSF to obtain a high proportion of proliferating cells. 
It appeared that prolonged labeling with IdUrd concentra­
tions of 2 pM and higher was toxic for CFU-GM (Fig. 4). The 
curves obtained with 2, 3, 4, and 5 pM showed no further 
decrease in CFU-GM number after 4- and 5-day exposure. 
This could indicate that IdUrd concentrations had decreased 
below toxic levels. Therefore, the concentration of IdUrd in 
time was investigated.
Sensitivity. Theoretically, 1 pM IdUrd could be too low to 
label all clonogenic cells in S-phase. Therefore, the percent­
age of positive colonies obtained after 24-hour labeling with 
5 pM (the highest non toxic concentration) as well as 1 pM 
and 0.5 pM were compared. It appeared that about 75% of
CFU-Molt-4 revealed no significant differences for the five 
tested samples (Table 1). The wide confidence intervals of the 
suicide technique contrasted with the small confidence inter­
vals obtained with IdUrd pulse-labeling.
In a second set of experiments, normal bone marrow cells 
were cultured for 4 days in the absence or presence of the
1 2 3 4 5
EXPOSURE PERIOD (DAYS)
Fig. 4. Toxicity of prolonged IdUrd labeling toward 
CFU-GM. Normal bone marrow cells were labeled with 
various concentrations of IdUrd for up to 5 days. Subse­
quently, the number of CFU-GM was determined and 
expressed as a percentage of the control cultures 
(100%) (incubated without idUrd). The graphic repre­
sents the mean percentage (±95% Cl) of three normal 
bone marrows. 13=0.5 pm, #=1.0 pm, A=2.0 pm, #=3.0 
pm, 0=4.0 pm, B^S.O pm, and A=10 um
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Fig. 5 . Signal intensity after prolonged IdUrd labeling. 
Normal bone marrow cells from three donors were 
labeled with various concentrations of IdUrd for 24 hours. 
Subsequently, clonogenic assays were performed. Cultures 
were ended after 6 days and the incorporated IdUrd was 
detected by immunoperoxidase staining. The diagram 
shows the mean (±95% Cl) percentage of IdUrd* colonies 
for each concentration of IdUrd.
the colonies were IdUrd* at all three concentrations tested 
(Fig. 5). This demonstrated that 1 pM IdUrd was sufficient to 
label all cycling cells during a period of at least 24 hours.
IdUrd concentration in time. The toxicity study indicated that 
1 pM IdUrd was the highest concentration that could be safe­
ly used for prolonged labeling. IdUrd can be inactivated, 
especially in media containing FCS not inactivated by heat 
(data not shown). The media used in this study contained 
heat-inactivated FCS. Since 1 pM or less IdUrd was below the 
detection limit of high-performance liquid chromatography 
(HPLC), a bioassay was performed. It appeared that IdUrd 
sufficient to label colony-forming cells for up to 5 days was 
present in the supernatants. The percentages of positive 
colonies were the same as obtained after exposure to a freshly 
prepared 1 pM solution (Fig. 6). However, the intensity of 
the signal in the colonies, cultured after incubation with the 
supernatant from days 4 and 5, was reduced.
Discussion
Suicide techniques are available to study the kinetics of 
colony-forming ceils in vitro. The fractional reduction in 
cloning efficiency after exposure to 3H-TdR, HU, or Ara-C 
may not always estimate the percentage of S-phase cells cor­
rectly [2,4,5]. Calculation of the suicide index is based on the 
subtraction and division of colony numbers. This is a major 
disadvantage of all suicide techniques. The confidence inter­
vals of colony-forming assays are substantial. A 95% Cl of 
-20% is not uncommon [3,21]. Statistically, this has a great 
impact on the accuracy of the suicide index. Calculation of 
the 95% Cl of the suicide index of some publications 
revealed a variation up to 30% [3,21].
Nonradioactive IdUrd appears to be an attractive alterna­
tive for determining the proportion of colony-forming cells
Fig. 6« IdUrd concentration in time. IL-3-, GM-CSF-, and 
G-CSF-stimulated normal bone marrow cells were incubat­
ed with supernatants collected after incubation of cell sus­
pensions with 1 pM IdUrd for a period of 1 to 5 days. As 
control, cells were also incubated with a freshly prepared 
1-pM IdUrd suspension (=day 0). After 24 hours, clono­
genic assays were performed. Cultures were ended after 6 
days and IdUrd was detected by immunoperoxidase stain­
ing. The mean (±95% Ci) percentage of ldUrd+ colonies 
reflects the residual amount of IdUrd which could be 
incorporated.
in S-phase, In contrast to the suicide techniques, the percent­
age of IdUrd* colonies per culture dish is independent of the 
variation in colony numbers. Instead, the exactness of the 
estimated percentage S-phase cells depends on the total num­
ber of analyzed colonies [20].
After adaptation of a protocol developed for immunologi­
cal detection of IdUrd by FCM, IdUrd* colonies could easily 
be detected in agar cultures (Fig. 1). The immunoperoxidase 
staining technique was sensitive enough to detect IdUrd in 
colonies consisting of maximally 64 cells.
Toxicity and sensitivity experiments indicated that a 2- 
hour exposure to 40 pM IdUrd was optimal for pulse-label­
ing. Underestimation of the percentage S-phase cells due to 
insufficient incorporated IdUrd was excluded by extensive 
studies with Molt-4 cells (Table 1). Molt-4 cells and normal 
bone marrow cells with varying percentages of cells in S- 
phase were used to compare IdUrd pulse-labeling with 3Ii- 
TdR suicide. The mean percentage of S-phase cells deter­
mined with IdUrd labeling was not significantly different 
from the percentage obtained with 3H-TdR suicide (Tables 1 
and 2). Due to the inevitable variation in colony numbers, 
the extent of the 95% CI of the suicide index was substantial. 
Based on the evaluation of only 200 aggregates, a much 
smaller confidence interval was calculated in case of IdUrd 
pulse-labeling. Thus, IdUrd pulse-labeling appeared to be 
more accurate than 3H-TdR suicide. A negative suicide index, 
which means higher colony numbers in the 3H-TdR exposed 
fraction, was observed in two samples. Both contained a low 
percentage of S-phase cells (4.2% and 14.8%, respectively, 
when determined with IdUrd pulse-labeling). The relatively 
small number of 3H-TdR killed cells fell probably within the 
variation of the colony-forming assays. Other authors have
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made identical observations [3,21]. It again shows a limita­
tion of suicide techniques.
Toxicity and inactivation of IdUrd and sensitivity of the 
IdUrd detection were evaluated to determine the optimal 
concentration for prolonged labeling. It appeared feasible to 
determine the proportion of cycling clonogenic cells for a 
period of at least 5 days during which a concentration of
1 pM IdUrd was used to label the cells. Thus, prolonged 
IdUrd labeling provides the unique opportunity to deter­
mine the proliferating fraction of progenitor cells. With the 
traditional techniques, only the fraction of S-phase cells can 
be determined.
During DNA repair, both 3H-TdR and IdUrd will be incor­
porated into non-S-phase cells. In theory, this could result in 
an overestimation of cells in S-phase. However, the number 
of repaired sites is relatively small compared to the doubling 
of DNA that occurs during S-phase. This suggests only a 
minor or even no detectable effect of DNA repair on the esti­
mation of cells in S-phase. In some leukemic samples, we 
observed that even during 3~day labeling with 1 pM IdUrd, 
<5% of the leukemic clonogenic cells were IdUrd+ (data not 
shown). This additionally supports the limited influence of 
DNA repair on the estimation of S-phase cells.
Prolonged and pulse-labeling with IdUrd can be applied to 
study the proliferative behavior of progenitors under physio­
logical and pathological conditions. For example, the effects 
of growth factors on the in vitro proliferation of normal and 
leukemic colony-forming cells can be analyzed. Furthermore, 
cycling data can be correlated to the cytotoxicity of chemo­
therapeutic drugs. IdUrd can safely be administered to 
humans [11,12], Kinetic analysis of in vivo labeled pro­
genitors seems feasible, and the first clinical data are current­
ly being collected in our institute.
The present study shows that the percentage of colony- 
forming cells in S-phase can be determined more accurately 
with IdUrd pulse-labeling than with suicide techniques. In 
addition, prolonged IdUrd labeling makes it possible to study 
the proliferating fraction of progenitor cells for at least 5 days.
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